A consensus review on the development of palliative care for patients with chronic and progressive neurological disease

European Journal of Neurology

Volumn 23, Issue 1, 2016, Pages 30-38

  Oliver, D J ^a,b   Borasio, G D ^c   Caraceni, A ^d,e   de Visser, M ^f   Grisold, W ^g   Lorenzl, S ^h   Veronese, S ⁱ   Voltz, R ^j,k  

^a Palliative Medicine   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g KAISER FRANZ JOSEF HOSPITAL   (Austria)

^h PARACELSUS MEDICAL UNIVERSITY   (Austria)

ⁱ Fondazione Assistenza e Ricerca in Oncologia (FARO) Onlus   (Italy)

^j UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^k EAN Subspeciality Scientific Panel on Palliative Care   (Austria)

more..

Author keywords

Collaborative care; Consensus; End of life; Palliative care; Progressive neurological disease

Indexed keywords

CONSENSUS; HUMAN; MEDICAL SOCIETY; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; NEUROLOGIC DISEASE; NEUROLOGY; PALLIATIVE THERAPY; STANDARDS; TERMINAL CARE;

CONSENSUS; HUMANS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES; NEUROLOGY; PALLIATIVE CARE; SOCIETIES, MEDICAL; TERMINAL CARE;

EID: 84955180334     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12889     Document Type: Review

References (68)

1. Borasio GD. The role of palliative care in patients with neurological disease. Nat Rev Neurol 2013; 9: 292-295.
2. World Health Organisation. Global burden of neurological disorders: estimates and projections. In: Aarli JA, Avanzini G, Bertolote JM, et al., eds. Neurological Disorders - Public Health Challenges. Geneva, Switzerland: World Health Organisation, 2006: 27-39.
3. Oliver D, Silber E. End of life care in neurological disease. In: Oliver D, ed. End of Life Care in Neurological Disease. London: Springer, 2012.
4. Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010; 17: 1236-1248.
5. Miller RG, Jackson CE, Karsarkis EJ, et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence-based review). Neurology 2009; 73: 1227-1233.
6. Andersen PM, Abrahams S, Borasio GD, et al. The EFNS task force on diagnosis and management of amyotrophic lateral sclerosis. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol 2012; 19: 360-375.
7. World Health Organization. Palliative care. 2002. http://www.who.int/cancer/palliative/definition/en/ (accessed 01/09/2013)
8. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. Eur J Neurol 2004; 11: 577-581.
9. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008; 336: 924-926.
10. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 19: 733-742.
11. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer; the Project ENABLE II randomised controlled trial. JAMA 2009; 19: 741-749.
12. Gaertner J, Wolf J, Hallek M, Glossmann J-P, Voltz R. Standardising integration of palliative care into comprehensive cancer therapy - a disease specific approach. Support Care Cancer 2011; 19: 1037-1043.
13. Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: a systematic review. JAMA 2008; 299: 1698-1709.
14. Edmonds P, Hart S, Gao W, et al. Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Mult Scler 2010; 16: 627-636.
15. Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage 2009; 38: 816-826.
16. Veronese S, Oliver D. Palliative Care for People with Neurodegenerative Conditions. Saarbrucken: Lambert Academic Publishing, 2013.
17. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003; 74: 1258-1261.
18. Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw PJ, MCDermott C. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14: 13-19.
19. Rooney J, Byrne S, Heverin M, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychaitry 2015; 86: 496-503.
20. Borasio GD, Sloan R, Pongratz DE. Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci 1998; 160(Suppl. 1): S127-S133.
21. Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES - A six step protocol for delivering bad news: application to the patient with cancer. Oncologist 2000; 5: 302-311.
22. Lienard A, Merckaert I, Libert Y, et al. Is it possible to improve residents breaking bad news skills? A randomised study assessing the efficacy of a communication skills training programme. Br J Cancer 2010; 103: 171-177.
23. Jacobsen J, Robinson E, Jackson VA, Meigs JB, Billings JA. Development of a cognitive model for advance care planning discussions: results from a quality improvement initiative. J Palliat Med 2011; 14: 331-336.
24. Jacobsen J, Jackson V, Dahlin C, et al. Components of early outpatient palliative care consultation in patients with metastatic non-small cell cancer. J Palliat Med 2011; 14: 459-464.
25. Voltz R, Akabayashi A, Reese C, Ohi G, Sass HM. End-of-life decisions and advance directives in palliative care: a cross cultural survey of patients and health-care professionals. J Pain Symptom Manage 1998; 16: 153-162.
26. Jox RJ, Krebs M, Bickhardt J, Hessdorfer K, Roller S, Borasio GD. How strictly should advance decisions be followed? The patients' opinion Palliat Med 2008; 22: 675-676.
27. Buecken R, Galushko M, Golla H, et al. Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues? Patient Educ Couns 2012; 88: 318-324.
28. Golla H, Galushko M, Pfaff H, Voltz R. Unmet needs of severely affected multiple sclerosis patients: the health professionals' views. Palliat Med 2011; 26: 139-151.
29. Lee MA, Prentice WM, Hildreth AJ, Walker RW. Measuring symptom load in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 284-289.
30. Hasson F, Kernohan WG, McLaughlin M, et al. An exploration into the palliative and end-of-life experiences of carers of people with Parkinson's disease. Palliat Med 2010; 24: 731-736.
31. Walbert T, Khan M. End of life symptoms and care in patients with primary malignant tumours: a systematic literature review. J Neurooncol 2014; 117: 217-224.
32. Payne S, Burton C, Addington-Hall J, Jones A. End-of-life issues in acute stroke care: a qualitative study of the experiences and preferences of patients and families. Palliat Med 2010; 24: 146-153.
33. Travers E, Jones K, Nichol J. Palliative care provision in Huntington's disease. Int J Palliat Nurs 2007; 13: 125-130.
34. Miyashita M, Narita Y, Sakamoto A, et al. Care burden and depression in caregivers caring for patients with intractable neurological diseases at home in Japan. J Neurol Sci 2009; 276: 148-152.
35. Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003; 209: 79-85.
36. Gelfman LP, Meier DE, Morrison RS. Does palliative care improve quality? A survey of bereaved family members. J Pain Symptom Manage 2008; 36: 22-28.
37. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14: 866-874.
38. Caap-Ahlgren M, Dehlin O. Factors of importance to the caregiver burden experienced by family caregivers of Parkinson's disease patients. Aging Clin Exp Res 2002; 14: 371-377.
39. Kissane DW, McKenzie M, Bloch S, Moskowitz C, McKenzie DP, O'Neill I. Family focussed grief therapy: a randomised controlled trial in palliative care and bereavement. Am J Psychiatry 2006; 163: 1208-1218.
40. Cipolletta S, Amicucci L. The family experience of living with a person with amyotrophic lateral sclerosis: a qualitative study. Int J Psychol 2015; 50: 288-294.
41. Morita T, Murata H, Kishi E, Miyashita M, Yamaguchi T, Uchitomi Y. Meaninglessness in terminally ill cancer patients: a randomised controlled study. J Pain Symptom Manage 2009; 37: 649-658.
42. Pereira SM, Fonseca AM, Carvalho AS. Burnout in palliative care: a systematic review. Nurs Ethics 2011; 18: 317-326.
43. Fillion l, Duval S, Dumont S, et al. Impact of meaning-centred intervention on job satisfaction and on quality of life among palliative care nurses. Psychooncology 2009; 18: 1300-1310.
44. Gouveia MC, Oliver DJ. Can emotional support for health care workers to cope with death anxiety reduce burnout and improve patient care. J Palliat Care 2011; 27: 287-295.
45. Neudert C, Wasner M, Borasio GD. Patients' assessment of quality of life instruments: a randomised controlled trial of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 103-109.
46. End of life care in long term neurological conditions: a framework for implementation. National End of Life Care Programme 2010.
47. Hussain J, Adams D, Allgar V, Campbell C. Triggers in advanced neurological conditions: prediction and management of the terminal phase. BMJ Support Palliat Care 2014; 4: 30-37.
48. Richfield EW, Jones EJS, Alty JE. Palliative care for Parkinson's disease: a summary of the evidence and future directions. Palliat Med 2013; 27: 805-810.
49. O'Brien T, Kelly M, Saunders C, Motor neurone disease: a hospice perspective. Br Med J 1992; 304: 471-473.
50. Bausewein C, Hau P, Borasio GD, Voltz R. How do patients with primary brain tumour die? Palliat Med 2003; 17: 558-559.
51. Voltz R, Galushko M, Walisko J, et al. Issues of 'life' and 'death' for patients receiving palliative care - comments when confronted with a research tool. Support Care Cancer 2011; 19: 771-777.
52. Stutzki R, Weber M, Reiter-Theil S, Simmen U, Borasio GD, Jox RJ. Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 68-76.
53. Maessen M, Veldink JH, Onwuteaka-Philipsen BD, et al. Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol 2014; 261: 1894-1901.
54. Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. N Engl J Med 1998; 339: 967-973.
55. Bascom PB, Tolle SW. Responding to requests for physician-assisted suicide: 'These are uncharted waters for both of us...'. JAMA 2002; 288: 91-98.
56. Ganzini L, Goy ER, Dobscha SK. Oregonians' reasons for requesting physician aid in dying. Arch Intern Med 2009; 169: 489-492.
57. Maessen M, Veldink JH, van den Berg LH, Schouten HJ, van der Wal G, Onwuteaka-Philipsen BD. Requests for euthanasia: origin of suffering in ALS, heart failure and cancer patients. J Neurol 2010; 257: 1192-1198.
58. Lulé D, Nonnenmacher S, Sorg S, et al. Live and let die: existential decision processes in a fatal disease. J Neurol 2014; 261: 518-525.
59. Ganzini L, Harvath TA, Jackson A, Goy ER, Miller LL, Delorit MA. Experiences of Oregon nurses and social workers with hospice patients who requested assistance with suicide. New Engl J Med 2002; 347: 582-588.
60. Di Leo S, Beccaro M, Finelli S, Borreani C, Constantini M. Expectations about and impact of the Liverpool Care Pathway for the Dying Patient. Palliat Med 2011; 25: 293-303.
61. Veerbeek L, van Zuylen L, Swart SJ, et al. The effect of the Liverpool Care of the Dying: a multi-centre study. Palliat Med 2008; 22: 145-151.
62. Carver AC, Vickrey BG, Bernat JL, Ringel SP, Foley KM. End-of-life care: a survey of US neurologists' attitudes, behavior and knowledge. Neurology 1999; 53: 284-293.
63. American Academy of Neurology. Palliative care in neurology. The American Academy of Neurology Ethics and Humanities Subcommittee. Neurology 1996; 46: 870-872.
64. Szmuilowicz E, El-Jawahri A, Chiappetta L, Kamdar M, Block S. Improving residents' end-of-life communication skills with a short retreat: a randomised controlled trial. J Palliat Med 2010; 13: 439-452.
65. McConigley R, Aoun S, Kristjanson L, et al. Implementation and evaluation of an education program to guide palliative care for people with motor neurone disease. Palliat Med 2012; 26: 994-1000.
66. Turner-Stokes L, Sykes N, Silber E, Khatri A, Sutton L, Young E. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions. Clin Med 2007; 7: 129-136.
67. Bede P, Oliver D, Stodart J, et al. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry 2011; 82: 413-418.
68. National Institute for Health and Care Excellence. Clinical Guideline 105: Motor Neurone Disease; the use of non-invasive ventilation in the management of motor neurone disease. NICE July 2010.